Video

Is AI Improving Outcomes In Clinical Trials?

The complexity of initiating clinical studies continues to grow. The complexity is a confluence of complicated protocols, globalization, and regulatory changes, all at a time when there is intense pressure to restrain costs and shorten timelines. The key to reducing these complexities is the ability to use machine learning to gain critical operational insights, which will allow organizations to learn and adapt. The insights gained will allow organizations to transition from subjective decisions to data-driven decisions.

In October 2020, Ed Miseta had the opportunity to sit down with Jennifer Goldsack of DiMe, Nechama Katan of Pfizer, Alex Zhavoronkov of Insilico Medicine, and Elvin Thalund of Oracle Health Sciences to discuss this topic.

VIEW THE VIDEO!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader